GARDP Webinar: How can non-profit drug developers counter AMR?
Antibiotics underpin modern medicine and are critical for pandemic preparedness. The aim of the webinar is to highlight the value of the nonprofit R&D business model in tackling antimicrobial resistance (AMR). It will look at the importance of public-private partnerships, such as GARDP, in accelerating the development and access to new and improved treatments for drug-resistant infections. The webinar will feature experts who have been deeply involved in the non-profit public health sector and are committed to introducing new health treatments for priority public health needs.
We will be joined by:
Laura Piddock, Scientific Director, GARDP
Pietro Turilli, Senior Vice President, External Affairs, TB Alliance
Monique Wasunna, Director, DNDi Eastern Africa
Moderated by: Claire Doole
More information is available on our website: https://gardp.org/events/webinar-how-can-a-nonprofit-drug-development-model-counter-amr/
The registration link is available here: Register here
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Global Ambassador Network
Welcome at the AMR Insights Ambassador Network!
The AMR Insights Ambassador Network is a growing, distinctive group of professionals who stand out for their commitment, willingness to cooperate and open attitude to combat Antimicrobial resistance (AMR).
